Metabolic abnormalities contributing to LV systolic and diastolic dysfunction or hypertrophy have been identified in animal models, including lipocyte apoptosis, insulin resistance with hyperinsulinemia, leptin resistance with hyperleptinemia, reduced adiponectin levels, and activation of the RAAS (Kenchaiah et al., 2002). Here, ADIPOQ is linked to Insulin resistance.